Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss potential strategies that teams can implement to ensure clinical trials are more representative of the general population.

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

Here’s what to know about Donald Trump’s NIH funding cuts. Americans are struggling with rising costs and high anxiety around ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Weight-loss jabs ‘slash alcohol cravings and curb heavy drinking’ - A new study adds to a growing body of evidence that ...

CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

The Trump Administration's cuts to medical research funding could force Brown University to stop many research projects and cut more than 200 RI jobs.